<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tau proteins are central to the neuropathology of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> and tau levels in cerebrospinal fluid are elevated in affected individuals </plain></SENT>
<SENT sid="1" pm="."><plain>In this study, we investigated the presence of tau in plasma from subjects with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (n = 16), <z:hpo ids='HP_0002145'>frontotemporal dementia</z:hpo> (n = 10), vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (n = 16) and from healthy controls (n = 15) </plain></SENT>
<SENT sid="2" pm="."><plain>By using an ELISA with monoclonal tau antibodies, tau immunoreactivity was detected in approximately 20% of the subjects </plain></SENT>
<SENT sid="3" pm="."><plain>However, no difference between the disease and control groups was seen </plain></SENT>
<SENT sid="4" pm="."><plain>After gel filtration of tau immunopositive plasma, the peak reactivity was found in the 160-kD fraction, indicating the source to be tau-like molecules of high-molecular-weight or polymers of low-molecular-weight tau isoforms </plain></SENT>
<SENT sid="5" pm="."><plain>We conclude that measurements of tau in plasma cannot be utilized diagnostically for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> or for the other <z:hpo ids='HP_0000726'>dementias</z:hpo> investigated </plain></SENT>
<SENT sid="6" pm="."><plain>Copyrightz1999S.KargerAG,Basel </plain></SENT>
</text></document>